Flat-Fixed Dosing Versus Body Surface Area–Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?

Abstract

Learning Objectives After completing this course, the reader will be able to: Describe how and why BSA-based dosing was implemented into oncology.Discuss if flat-fixed dosing of adults has advantages over BSA-based dosing in terms of interpatient pharmacokinetic variation of anticancer drugs, efficiency, and costs.Explain which alternative dosing strategies for BSA-based dosing may have potential, leading to a minimum of adverse events and superior therapeutic outcome. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com